THE MEDTECH CONFERENCE 2026

Attendees, exhibitors & solutions

Who this event is for

Industry trends

Key trends shaping this market and its wider industry.

Arrival airports

Choose from the following airports, with convenient access to the event and venue.

Hotel tiers

A range of accommodation options near the venue and across key areas.

Local transport

Get around the city with these convenient transport options.

Frequently asked

Glossary

1

AdvaMed

The US medical technology industry association that organises The MedTech Conference; membership status also determines which registration tier and rate an attendee pays.

2

510(k) clearance

The most common FDA premarket pathway in the US, used when a new device is substantially equivalent to an already marketed predicate device.

3

PMA (Premarket Approval)

The FDA's most stringent device review route, required for high-risk Class III devices where the applicant must supply its own clinical and manufacturing evidence.

4

De Novo classification

An FDA pathway for novel low or moderate risk devices that have no valid predicate, creating a new device type once granted.

5

Breakthrough Devices Program

An FDA programme giving expedited interaction and review priority to devices that offer more effective treatment or diagnosis of life-threatening or irreversibly debilitating conditions.

6

IDE (Investigational Device Exemption)

FDA authorisation that allows a device to be used in a clinical study to collect the safety and effectiveness data needed for a future marketing submission.

7

CDRH

The FDA's Center for Devices and Radiological Health, the division responsible for reviewing and regulating medical devices sold in the United States.

8

UDI (Unique Device Identification)

A US labelling and tracking system that assigns each device model a unique code to improve traceability, recalls and post-market surveillance.

9

SaMD (Software as a Medical Device)

Software intended for a medical purpose that runs on general-purpose computing platforms rather than being part of a hardware device; regulated separately from the hardware it supports.

10

QMS / ISO 13485

The quality management system framework for medical device design, manufacture and servicing; ISO 13485 is the international standard most regulators and partners expect to see.

11

EU MDR and IVDR

The European Union's Medical Device Regulation and In Vitro Diagnostic Regulation, which set clinical evidence, classification and post-market requirements for access to the EU market.

12

Real-World Evidence (RWE)

Clinical evidence derived from routine care data such as registries, electronic records and claims, increasingly used to support regulatory and payer decisions after launch.

13

Reimbursement and coverage

The US pathway by which payers such as Medicare and commercial insurers agree to cover and pay for a device or procedure; coverage strategy often decides commercial success regardless of clearance.

14

Combination product

A therapeutic or diagnostic product that combines two or more regulated components, for example a drug-coated device or a device with an embedded biologic, which triggers cross-centre FDA review.

15

CDMO

A contract development and manufacturing organisation that designs, builds or assembles devices or components for other medtech companies, a common exhibitor and partner category at industry conferences.

16

Accel start-up tier

The early-stage company registration band at The MedTech Conference, used for pre-revenue medtech ventures and emerging companies below stated revenue thresholds.